4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001470831-26-000180
Chief Business Officer gave up 9,004 shares (to pay taxes)
- Chief Business Officer acquired 200,000 shares (grant or award)
- Chief Business Officer acquired 25,950 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Boyle Scott N Chief Business Officer | 2026-02-13 | Grant or award | +200,000 | 307,805 | D: show line 1 in the form | ||
| Boyle Scott N Chief Business Officer | 2026-02-13 | Option exercise | +5,000 | 307,805 | D: show line 2 in the form | ||
| Boyle Scott N Chief Business Officer | 2026-02-13 | Shares withheld for taxes | −1,735 | $1.89 | $3,279 | 306,070 | D: show line 3 in the form |
| Boyle Scott N Chief Business Officer | 2026-02-14 | Option exercise | +20,950 | 306,070 | D: show line 4 in the form | ||
| Boyle Scott N Chief Business Officer | 2026-02-14 | Shares withheld for taxes | −7,269 | $1.89 | $13,738 | 298,801 | D: show line 5 in the form |
Loading xslF345X05/wk-form4_1771452315.xml…